APA (7th ed.) Citation

Hadia, R., Maheshwari, R., & Bhil, D. (2025). Observational Study on Hematological Adverse Drug Reactions (HADRs) from Hydroxyurea in Pediatric Patients with Sickle Cell Disease (SCD): Assessing Prevalence, Causality, Severity, Preventability, and Predictability, along with Clinical Management by a Clinical Pharmacist at a Tertiary Care Teaching Hospital. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Hadia, Rajesh, Rajesh Maheshwari, and Dipika Bhil. Observational Study on Hematological Adverse Drug Reactions (HADRs) from Hydroxyurea in Pediatric Patients with Sickle Cell Disease (SCD): Assessing Prevalence, Causality, Severity, Preventability, and Predictability, Along with Clinical Management by a Clinical Pharmacist at a Tertiary Care Teaching Hospital. Wolters Kluwer Medknow Publications, 2025.

MLA (9th ed.) Citation

Hadia, Rajesh, et al. Observational Study on Hematological Adverse Drug Reactions (HADRs) from Hydroxyurea in Pediatric Patients with Sickle Cell Disease (SCD): Assessing Prevalence, Causality, Severity, Preventability, and Predictability, Along with Clinical Management by a Clinical Pharmacist at a Tertiary Care Teaching Hospital. Wolters Kluwer Medknow Publications, 2025.